Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
T CELL FOR EFFICIENTLY AND STABLY EXPRESSING ANTIBODY AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/219933
Kind Code:
A1
Abstract:
Provided is a transgenic T cell. A genome of the T cell stably integrates an expression cassette comprising an encoding sequence of an antibody in a human FC fragment, and two ends of the expression cassette comprise an inverted terminal repeat sequence of transposons. Also provided are a pharmaceutical combination comprising the transgenic T cell and an application thereof.

Inventors:
QIAN QIJUN (CN)
JIN HUAJUN (CN)
XU JIEYING (CN)
LI LINFANG (CN)
YE ZHENLONG (CN)
WANG CHAO (CN)
JIANG DUQING (CN)
WU HONGPING (CN)
Application Number:
PCT/CN2017/088952
Publication Date:
December 28, 2017
Filing Date:
June 19, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI CELL THERAPY RES INST (CN)
SHANGHAI ENGINEERING RES CENTER FOR CELL THERAPY GROUP CO LTD (CN)
International Classes:
C12N5/10; A61K35/17; A61K48/00; A61P35/00; C12N15/13; C12N15/85
Foreign References:
CN105154473A2015-12-16
CN104745581A2015-07-01
CN105330750A2016-02-17
Other References:
SAHA, S. ET AL.: "piggyBac Transposon System Modification of Primary Human T Cells", JOURNAL OF VISUALIZED EXPERIMENTS, vol. 69, 11 May 2012 (2012-05-11), pages 1 - 5, XP055181355, ISSN: 1940-087X
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: